Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
hautnah
Erschienen in:

16.04.2018 | Ästhetische Dermatologie

Anti-Aging-Strategien

Innovative Konzepte für die Entwicklung von Anti-Aging-Dermokosmetika

verfasst von: Prof. Dr. Cornelia M. Keck

Erschienen in: hautnah | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Effektive Anti-Aging-Wirkstoffe können nur dann entwickeltwerden, wenn der Alterungsprozess vollständig verstanden ist. Da dies bis heute noch nicht vollständig der Fall ist, sind derzeit nur solche Wirkstoffe verfügbar, die in bereits verstandene Teilbereiche des Alterungsprozesses eingreifen können. Der Beitrag umreißt die wesentlichen heute bekannten Anti-Aging-Strategien und erläutert, basierend darauf, neue und innovative Konzepte für die Entwicklung von Anti-Aging-Dermokosmetika.
Vorheriger Artikel Behandlungsmöglichkeiten mit Chemical Peeling
Nächster Artikel „Die Flöhe und die Wanzen gehören auch zum Ganzen“ (Johann Wolfgang von Goethe)
Literatur
1.
Köckritz A (2001) Flüsse aus Quecksilber. Zeit 11(26):3
2.
3.
Hasworth SB, Cannon ML (2015) Social theories of aging: a review. Dis Mon 61(11):475–479PubMedCrossRef
4.
Avantaggiato A et al (2015) The theories of aging: reactive oxygen species and what else? J Biol Regul Homeost Agents 29(3Suppl 1):156–163PubMed
5.
6.
Libertini G (2015) Non-programmed versus programmed aging paradigm. Curr Aging Sci 8(1):56–68PubMedCrossRef
7.
Goldsmith TC (2015) Is the evolutionary programmed/non-programmed aging argument moot? Curr Aging Sci 8(1):41–45PubMedCrossRef
8.
Aledo JC, Blanco JM (2015) Agingisneitherafailure nor an achievement of natural selection. Curr Aging Sci 8(1):4–10PubMedCrossRef
9.
Cohen AA (2016) Complex systems dynamics in aging: new evidence, continuing questions. Biogerontology 17(1):205–220PubMedCrossRef
10.
11.
Piotrowska A, Bartnik E (2014) The role of reactive oxygen species and mitochondria in aging. Postepy Biochem 60(2):240–247PubMed
12.
Sikora E (2014) Aging and longevity. Postepy Biochem 60(2):125–137PubMed
13.
Liochev SI (2015) Reflections on the theories of aging, of oxidative stress, and of science in general. Is it time to abandon the free radical (oxidative stress) theory of aging? Antioxid Redox Signal 23(3):187–207PubMedCrossRef
14.
Fulop T et al (2014) On the immunological theory of aging. Interdiscip Top Gerontol 39:163–176PubMedCrossRef
15.
Zs-Nagy I (2014) Aging of cell membranes: facts and theories. Interdiscip Top Gerontol 39:62–85PubMedCrossRef
16.
Le Bourg E (2014) Evolutionary theories of aging can explain why we age. Interdiscip Top Gerontol 39:8–23PubMedCrossRef
17.
18.
19.
Hardeland R (2013) Melatonin and the theories of aging: a critical appraisal of melatonin’s role in antiaging mechanisms. J Pineal Res 55(4):325–356PubMed
20.
21.
Xi H et al (2013) Telomere, aging and age-related diseases. Aging Clin Exp Res 25(2):139–146PubMedCrossRef
22.
23.
Naito AT, Komuro I (2013) Chronic inflammation andorganismal aging. Clin Calcium 23(1):51–58PubMed
24.
25.
Jenny NS (2012) Inflammation in aging: cause, effect, or both? Discov Med 13(73):451–460PubMed
26.
27.
Weinert BT, Timiras PS (1985) Invited review: theories of aging. J Appl Physiol 95(4):1706–1716CrossRef
28.
Medvedev ZA (1990) An attempt at a rational classification of theories of ageing. Biol Rev Camb Philos Soc 65(3):375–398PubMedCrossRef
29.
Huber J, Buchacher R (2007) Das Ende des Alterns: Bahnbrechende medizinische Möglichkeiten der Verjüngung. Ullstein, Berlin
30.
Stipp D (2010) The youth pill: scientists at the brink of an anti-aging revolution. Penguin Group, Current
31.
32.
Busse EW (1969) Onemedical school’s approach to teaching problems of the aging. J Am Geriatr Soc 17(3):299–314PubMedCrossRef
33.
Anstey K, Stankov L, Lord S (1993) Primary aging, secondary aging, and intelligence. Psychol Aging 8(4):562–570PubMedCrossRef
34.
Robinson LJ et al (2003) Proteomic analysis of the genetic premature aging disease Hutchinson Gilford progeria syndrome reveals differential protein expression and glycosylation. J Proteome Res 2(5):556–557PubMedCrossRef
35.
Brown WT (1992) Progeria: a human-disease model of accelerated aging. Am J Clin Nutr 55(6 Suppl):S1222–S1224CrossRef
36.
Brown WT, Zebrower M, Kieras FJ (1985) Progeria, a model disease for the study of accelerate daging. Basic Life Sci 35:375–396PubMed
37.
Blancquaert A (1959) Progeria & progeria-like disease. Maandschr Kindergeneeskd 27(5):157–171PubMed
38.
Paglia DE, Walford RL (2005) Atypical hematological response to combined calorie restriction and chronic hypoxia in biosphere 2 crew: a possible link to latent features of hibernation capacity. Habitation (Elmsford) 10(2):79–85CrossRef
39.
Walford RL et al (2002) Calorie restriction in biosphere 2: alterations in physiologic, hematologic, hormonal, andbiochemicalparameters inhumans restricted for a 2-year period. J Gerontol A Biol Sci Med Sci 57(6):B211–B224PubMedCrossRef
40.
Walford RL et al (1999) Physiologic changes in humans subjected to severe, selective calorie restriction for two years in biosphere 2: health, aging, and toxicological perspectives. Toxicol Sci 52(2Suppl):61–65PubMed
41.
Al-Regaiey KA (2016) The effects of calorie restriction on aging: a brief review. Eur Rev Med Pharmacol Sci 20(11):2468–2473PubMed
42.
43.
Salvatore MF et al (2016) Initiation of calorie restriction in middle-aged male rats attenuates aging-related motoric decline and bradykinesia without increased striatal dopamine. Neurobiol Aging 37:192–207PubMedCrossRef
44.
Trubitsyn AG (2015) The lag of the proliferative aging clock underlies thelifespan-extending effect of calorie restriction. Curr Aging Sci 8(3):220–226PubMedCrossRef
45.
Karunadharma PP et al (2015) Subacute calorie restriction and rapamycin discordantly alter mouse liver proteome homeostasis and reverse aging effects. Aging Cell 14(4):547–557PubMedPubMedCentralCrossRef
46.
Xu C et al (2015) Calorie restriction prevents metabolic aging caused by abnormal SIRT1 function in adipose tissues. Diabetes 64(5):1576–1590PubMedCrossRef
47.
Kim DH et al (2015) The roles of FoxOs in modulation of aging by calorie restriction. Biogerontology 16(1):1–14PubMedCrossRef
48.
Kim DH et al (2014) The essential role of FoxO6 phosphorylation in aging and calorie restriction. Age (Dordr) 36(4):9679CrossRef
49.
Michan S (2014) Calorie restriction and NAD(+)/sirtuin counteract the hallmarks of aging. Front Biosci 19:1300–1319CrossRef
50.
Testa G et al (2014) Calorie restriction and dietary restriction mimetics: a strategy for improving healthy aging and longevity. Curr Pharm Des 20(18):2950–2977PubMedCrossRef
51.
Yamada Y et al (2013) Long-term calorie restriction decreases metabolic cost of movement and prevents decrease of physical activity during aging in rhesus monkeys. Exp Gerontol 48(11):1226–1235PubMedCrossRef
52.
53.
Chung KW et al (2013) Recent advances in calorie restriction research on aging. Exp Gerontol 48(10):1049–1053PubMedCrossRef
54.
Drewnowski A et al (1996) Diet quality and dietary diversity in France: implications for the French paradox. J Am Diet Assoc 96(7):663–669PubMedCrossRef
55.
56.
Renaud S, de Lorgeril M (1993) The French paradox: dietary factors and cigarette smoking-related health risks. Ann N Y Acad Sci 686:299–309PubMedCrossRef
57.
Renaud S, de Lorgeril M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339(8808):1523–1526PubMedCrossRef
58.
Richard JL (1987) Coronary risk factors. The French paradox. Arch Mal Coeur Vaiss 80(SpecNo):17–21PubMed
59.
Yang X, Li X, Ren J (2014) From French paradox to cancer treatment: anti-cancer activities and mechanisms of resveratrol. Anticancer Agents Med Chem 14(6):806–825PubMedCrossRef
60.
Goldfinger TM (2003) Beyond the French paradox: the impact of moderate beverage alcohol and wine consumption in the prevention of cardiovascular disease. Cardiol Clin 21(3):449–457PubMedCrossRef
61.
Yarnell JW, Evans AE (2000) The Mediterranean diet revisited – towards resolving the (French) paradox. QJM 93(12):783–785PubMedCrossRef
62.
Renaud S, Gueguen R (1998) The French paradox and wine drinking. Novartis Found Symp 216:208–217 (discussion217–22,152–8)PubMed
63.
Kapoor VK, Dureja J, Chadha R (2009) Synthetic drugs with anti-ageing effects. Drug Discov Today 14(17–18):899–904PubMedCrossRef
64.
Harman D (1982) Nutritional implications of the free-radical theory of aging. J Am Coll Nutr 1(1):27–34PubMedCrossRef
65.
66.
67.
68.
Harman D (1992) Free radical theory of aging: history. EXS 62:1–10PubMed
69.
Harman D (1993) Freeradical involvementinaging. Pathophysiology and therapeutic implications. Drugs Aging 3(1):60–80PubMedCrossRef
70.
Harman D (1994) Free-radical theory of aging. Increasing the functional life span. Ann N Y Acad Sci 717:1–15PubMedCrossRef
71.
72.
Harman D (1998) Aging and oxidative stress. J Int Fed Clin Chem 10(1):24–27PubMed
73.
74.
Harman D (2000) Antioxidant supplements: effects on disease and aging in the United States population. J Am Aging Assoc 23(1):25–31PubMedPubMedCentral
75.
76.
77.
Harman D (2006) Free radical theory of aging: an update: increasing the functional lifespan. Ann N Y Acad Sci 1067:10–21PubMedCrossRef
78.
Harman D (2009) About „Origin and evolution of the free radical theory of aging: a brief personal history, 1954–2009“. Biogerontology 10(6):783PubMedCrossRef
79.
Lichtenstein AH, Russell RM (2005) Essential nutrients: food or supplements? Where should the emphasis be? JAMA 294(3):351–358PubMedCrossRef
80.
Murphy SP et al (2007) Multivitamin-multimineral supplements’ effect on total nutrient intake. Am J Clin Nutr 85(1):280–284
81.
Penniston KL, Tanumihardjo SA (2003) Vitamin A in dietary supplements and fortified foods: too much of a good thing? J Am Diet Assoc 103(9):1185–1187PubMedCrossRef
82.
Tomada I, Andrade JP (2015) Science based antiageing nutritional recommendations (Chapter 11). In: Neves D (Hrsg) Anti-ageing nutrients: evidence based prevention of age-associated diseases. Wiley, Hoboken, S 365–390
83.
Diamanti-Kandarakis E et al (2017) Mechanisms in endocrinology: aging and anti-aging: a combo-endocrinology overview. Eur J Endocrinol 176(6):R283–R308PubMedCrossRef
84.
Morley JE (2013) Scientific overview of hormone treatment used for rejuvenation. Fertil Steril 99(7):1807–1813PubMedCrossRef
85.
Zdanys KF, Steffens DC (2015) Sleep disturbances in the elderly. Psychiatr Clin North Am 38(4):723–741PubMedCrossRef
86.
87.
Manchester LC et al (2015) Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J Pineal Res 59(4):403–419PubMedCrossRef
88.
Ramis MR et al (2015) Protective effects of melatonin and mitochondria-targeted antioxidants against oxidative stress: a review. Curr Med Chem 22(22):2690–2711PubMedCrossRef
89.
Ramis MR et al (2015) Caloric restriction, resveratrol and melatonin: role of SIRT1 and implications for aging and related-diseases. Mech Ageing Dev 146–148:28–41PubMedCrossRef
90.
Karaaslan C, Suzen S (2015) Antioxidant properties of melatonin and its potential action in diseases. Curr Top Med Chem 15(9):894–903PubMedCrossRef
91.
Jenwitheesuk A et al (2014) Melatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathways. Int J Mol Sci 15(9):16848–16884PubMedPubMedCentralCrossRef
92.
93.
94.
Reiter RJ et al (2002) Melatonin, longevity and health in the aged: an assessment. Free Radic Res 36(12):1323–1329PubMedCrossRef
95.
Tanaka Y et al (1999) Effect of metformin on advanced glycation endproduct formation and peripheral nerve function in streptozotocin-induced diabetic rats. Eur J Pharmacol 376(1–2):17–22PubMedCrossRef
96.
Ouslimani N et al (2007) Metformin reduces endothelial cell expression ofboth the receptor for advanced glycation end products and lectin-like oxidizedreceptor 1. Metabolism 56(3):308–313PubMedCrossRef
97.
Beisswenger P, Ruggiero-Lopez D (2003) Metformin inhibition of glycation processes. Diabetes Metab 29(4Pt2):6S95–6103PubMed
98.
Ishibashi Y et al (2013) Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase. Horm Metab Res 45(5):387–390PubMed
99.
Carmona JJ, Michan S (2016) Biology of healthy aging and longevity. Rev Invest Clin 68(1):7–16PubMed
100.
101.
102.
103.
Ramos-e-Silva M et al (2013) Anti-aging cosmetics: facts and controversies. Clin Dermatol 31(6):750–758PubMedCrossRef
104.
Trommer H, Böttcher R, Neubert RHH (2002) Ascorbinsäure – Ein Vitamin wie Dr. Jekyll und Mr. Hyde. PZ-Pharmazeutische Zeitung – online, 2002. 48. http://​www.​pharmazeutische-zeitung. de/index.php?id=24758. Zugegriffen: 25. Juli 2017
105.
SteilingH RM (2009) Castiel I. Bioavaialability and skin bio afficacy of Vitamin C and E. In: Tabor A, Blair RM (Hrsg) Nutritional cosmetics: beauty from within. Elsevier ,William Andrew, Amsterdam, S 113–138
106.
Leveque N et al (2002) Decrease in skin ascorbic acid concentration with age. Eur J Dermatol 12(4):XXI–XXIIPubMed
107.
Passi S et al (2002) Lipophilic antioxidants in human sebum and aging. Free Radic Res 36(4):471–477PubMedCrossRef
108.
Vidlarova L et al (2016) Nanocrystals for dermal penetration enhancement –effect of concentration and underlying mechanisms using curcumin as model. Eur J Pharm Biopharm 104:216–225PubMedCrossRef
109.
Romero GB et al (2015) Industrial concentrates of dermal hesperidin smartCrystals®-production, characterization & long-term stability. Int J Pharm 482(1–2):54–60PubMedCrossRef
110.
Al Shaal L, Müller RH, Shegokar R (2010) smartCrystal combination technology – scale up from lab to pilot scale and long term stability. Pharmazie 65(12):877–884PubMed
111.
Keck CM, Müller RH (2008) Nanodiamanten – Erhöhte Bioaktivität. Labor More 1:64–65
112.
Keck CM, Chen R, Müller RH (2013) SmartCrystals for consumer care & cosmetics: enhanced dermal delivery of poorly soluble plant actives. Househ Pers Care Today 8(5):18–24
113.
114.
Sparavigna A, Tenconi B, De Ponti I (2015) Antiaging, photoprotective, and brightening activity in biorevitalization: a new solution for aging skin. Clin Cosmet Investig Dermatol 8:57–65PubMedPubMedCentralCrossRef
115.
Zastrow L, Lademann J (2016) Light – instead of UV protection: new requirements for skin cancer prevention. Anticancer Res 36(3):1389–1393PubMed
116.
Darvin ME et al (2010) Radical production by infrared A irradiation in human tissue. Skin Pharmacol Physiol 23(1):40–46PubMedCrossRef
117.
Darvin ME et al (2010) Formation of free radicals in human skin during irradiation with infrared light. J Invest Dermatol 130(2):629–631PubMedCrossRef
118.
Zastrow L et al (2009) UV, visible and infrared light. Which wavelengths produce oxidative stress in human skin? Hautarzt 60(4):310–317PubMedCrossRef
119.
Zastrow L et al (2009) The missing link – light induced (280–1,600 nm) free radical formation in human skin. Skin Pharmacol Physiol 22(1):31–44PubMedCrossRef
120.
Puri P et al (2017) Effects of air pollution on the skin: a review. Indian J Dermatol Venereol Leprol 83(4):415–423PubMedCrossRef
121.
122.
Kim KE, Cho D, Park HJ (2016) Air pollution and skin diseases: adverse effects of airborne particulate matter on various skin diseases. Life Sci 152:126–134PubMedCrossRef
123.
Krutmann J et al (2016) Environmentally induced (extrinsic) skinaging. Hautarzt 67(2):99–102PubMedCrossRef
124.
Li M et al (2015) Epidemiological evidence that indoor air pollution from cooking with solid fuels accelerates skin aging in Chinese women. J Dermatol Sci 79(2):148–154PubMedCrossRef
125.
Pan TL et al (2015) The impact of urban particulate pollution on skin barrier function and the subsequent drug absorption. J Dermatol Sci 78(1):51–60PubMedCrossRef
126.
Hsu S (2015) Compounds derived from Epigallocatechin-3-Gallate (EGCG) as a novel approach to the prevention of viral infections. Inflamm Allergy Drug Targets 14(1):13–18PubMedCrossRef
127.
Kong HH, Segre JA (2017) The molecular revolution in cutaneous biology: investigating the skin microbiome. J Invest Dermatol 137(5):e119–e122PubMedCrossRef
128.
Kirker KR, James GA (2017) In vitro studies evaluating the effects of biofilms on woundhealing cells: a review. APMIS 125(4):344–352PubMedCrossRef
129.
Igawa S, Di Nardo A (2017) Skin microbiome and mast cells. Trans L Res 184:68–76CrossRef
130.
131.
132.
133.
134.
135.
Zealley B, de Grey AD (2013) Strategies for engineered negligible senescence. Gerontology 59(2):183–189PubMedCrossRef
136.
Kaushik G, Leijten J, Khademhosseini A (2017) Concise review: organ engineering: design, technology, and integration. Stem Cells 35(1):51–60PubMedCrossRef
137.
Husain SR, Ohya Y, Puri RK (2017) Current status and challenges of three-dimensional modeling and printing of tissues and organs. Tissue Eng Part A 23(11–12):471–473PubMedCrossRef
138.
Jakus AE, Rutz AL, Shah RN (2016) Advancing the field of 3D biomaterial printing. Biomed Mater 11(1):14102PubMedCrossRef
139.
Metadaten
Titel
Anti-Aging-Strategien
Innovative Konzepte für die Entwicklung von Anti-Aging-Dermokosmetika
verfasst von
Prof. Dr. Cornelia M. Keck
Publikationsdatum
16.04.2018
Verlag
Springer Vienna
Erschienen in
hautnah / Ausgabe 2/2018
Print ISSN: 1866-2250
Elektronische ISSN: 2192-6484
DOI
https://doi.org/10.1007/s12326-018-0274-8

Weitere Artikel der Ausgabe 2/2018

Chronisches Ulkus nach Südostasienreise bei 24‑jährigem Mann

  • Fallbericht

Was wird aus „gesunder Bräune“ in 25 Jahren?

  • aktuell

„Du siehst aber schlecht aus!“: Was das Gesicht verrät

Behandlungsmöglichkeiten mit Chemical Peeling

  • Interview

Risiko für Zoster unter systemischer Therapie nicht erhöht

  • aktuell

Verhaltenstraining hilft, den Kratzdrang zu beherrschen

  • aktuell
Bildnachweise